Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanocurcumin in children with trauma-associated sepsis
IRCT20260510069335N1Phase 2Recruiting
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of nanocurcumin in sepsis, sponsored by Mashhad University of Medical Sciences. Started Jun 2026; status: recruiting.
02
Drugs
nanocurcumin
03
Conditions
sepsis
Beyond the preview
Go deeper on IRCT20260510069335N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260510069335N1.